10X Genomics Inc (TXG) — Strategic Asset Allocation Index
10X Genomics Inc (TXG) has a Strategic Asset Allocation Index of 47.5% as of September 2023. Strategic assets (PP&E of $354.20 Million plus long-term investments of $-) total $354.20 Million, measured against net assets of $745.22 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
10X Genomics Inc Strategic Asset Allocation Index (2019–2022)
This chart shows how 10X Genomics Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of September 2023, the index stands at 47.5%, representing strategic assets of $354.20 Million against net assets of $745.22 Million USD. Explore 10X Genomics Inc (TXG) cash conversion ratio to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for 10X Genomics Inc (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for 10X Genomics Inc from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see TXG company net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 35.9% | $289.33 Million | $289.33 Million | $- | $805.74 Million | ▲ +7.7 pp |
| 2021 | 28.2% | $230.41 Million | $230.41 Million | $- | $817.57 Million | ▲ +18.3 pp |
| 2020 | 9.9% | $72.84 Million | $72.84 Million | $- | $739.07 Million | ▼ -1.8 pp |
| 2019 | 11.6% | $48.82 Million | $48.82 Million | $- | $420.08 Million | — |